Raymond James Reiterates Outperform Rating on Guardant Health (GH)
Tweet Send to a Friend
Raymond James analyst Andrew Cooper reiterated an Outperform rating and $61.00 price target on Guardant Health (NASDAQ: GH).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
